Mitchell Sinkler & Starr Dexcom Inc Transaction History
Mitchell Sinkler & Starr
- $387 Million
- Q2 2024
A detailed history of Mitchell Sinkler & Starr transactions in Dexcom Inc stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 2,838 shares of DXCM stock, worth $193,296. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,838
Previous 1,638
73.26%
Holding current value
$193,296
Previous $227,000
41.41%
% of portfolio
0.08%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding DXCM
# of Institutions
1,112Shares Held
364MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.17 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.35 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.11 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.04 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$814 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...